Want to see JP:4594 full AI Analyst Report?

BrightPath Biotherapeutics Co.Ltd. (4594) Cash flow

0 Followers

BrightPath Biotherapeutics Co.Ltd. Cash Flow

JP:4594's free cash flow for Q4 2025 was ¥0.00. For the 2025 fiscal year, JP:4594's free cash flow was decreased by ¥-114.71M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.

Cash Flow	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Operating Cash Flow	¥ -1.37B	¥ -1.25B	¥ -1.16B	¥ -1.20B	¥ -1.51B
Investing Cash Flow	¥ -1.93M	¥ -1.37M	¥ -7.65M	¥ -1.76M	¥ -17.57M
Financing Cash Flow	¥ 2.71B	¥ 1.00B	¥ 690.96M	¥ 432.10M	¥ 569.23M
End Cash Position	¥ 2.16B	¥ 810.47M	¥ 1.06B	¥ 1.53B	¥ 2.31B
Free Cash Flow	¥ -1.37B	¥ -1.25B	¥ -1.16B	¥ -1.21B	¥ -1.53B

Currency in JPY